Updated:
Bora Pharmaceuticals Co., Ltd./ADR
Bora Pharmaceuticals Co., Ltd. is a Taiwan-based pharmaceutical manufacturer and CDMO, with an ADR trading over-the-counter.
Bora Pharmaceuticals Co., Ltd./ADR
Bora Pharmaceuticals was founded in 1995 and is based in Taiwan. The company's ADR (American Depositary Receipt) trades over-the-counter, giving international investors exposure to its operations. Wealth origin traces to the company's founding and growth within the pharmaceutical industry, though no specific founding family or principal is named in public records. The company's strategy centers on contract manufacturing and development services for pharmaceutical clients. It focuses on oral solid dosage forms, including tablets and capsules, and provides services ranging from formulation development to commercial production. Bora serves generic drug makers and specialty pharmaceutical companies across Asia, North America, and Europe. Its manufacturing facilities are located in Taiwan and China. Bora Pharmaceuticals has multiple subsidiaries, including Bora Pharmaceutical Services and Bora Laboratories. The company does not disclose total professionals or AUM as a pharmaceutical firm rather than an investment vehicle. It has no known philanthropic structures or asset management arms. The structural differentiator is its hybrid role as a listed pharmaceutical manufacturer and CDMO, which provides operational cash flows distinct from a family office or asset manager. The ADR structure allows US investors to trade shares without direct exposure to Taiwan's local exchange.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
—
Country
—
City
—
Corporate office
—
Frequently asked questions
What is Bora Pharmaceuticals' core business?
Bora Pharmaceuticals is a pharmaceutical company and contract development and manufacturing organization (CDMO) that produces oral solid dosage forms such as tablets and capsules. It serves generic and specialty drug clients globally, offering services from development through commercial manufacturing (per public record).
Where are Bora Pharmaceuticals' manufacturing facilities located?
The company operates manufacturing facilities in Taiwan and China. These sites are focused on oral solid dosage form production and support its CDMO operations across Asia, North America, and Europe (per public record).
Is Bora Pharmaceuticals a family office or investment firm?
No, Bora Pharmaceuticals is a publicly listed pharmaceutical manufacturer. Its ADR trades over-the-counter in the US. It does not operate as a family office or asset manager and is classified as an operating company within the pharmaceutical sector.
Does Bora Pharmaceuticals have investment or philanthropic arms?
There is no public disclosure of separate investment or philanthropic structures. The company appears to operate solely as a pharmaceutical manufacturing and CDMO business, with no known asset management or foundation vehicles.
What is the size of Bora Pharmaceuticals?
Exact revenue, employee count, and market capitalization are not available from the current inputs. The company trades via ADR and lists on the OTC markets, but specific financial metrics are not provided in this profile's source materials.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: